Schilde
Belgium
35
2025-07-17
The entities that hold a legal rights for patent applications filed by inventor Kas Koen:
Koen Kas from Schilde, BE has applied for patents for these inventions. The list has both pending applications and granted patents:
USE OF APTAMERS IN PROTEOMICS
#2 | 2022-10-13Use of aptamers in proteomics
#3 | 2022-01-06Use of aptamers in proteomics
#4 | 2019-12-19Use of aptamers in proteomics
#5 | 2018-02-01Use of aptamers in proteomics
#6 | 2017-01-12Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
#7 | 2016-08-25LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#8 | 2016-02-25Biomarkers for hypertensive disorders of pregnancy
#9 | 2016-02-18BIOMARKER FOR DIAGNOSIS, PREDICTION AND/OR PROGNOSIS OF ACUTE HEART FAILURE AND USES THEREOF
#10 | 2016-02-18LTBP2 AS A BIOMARKER FOR EVALUATING THE RISK OF DEATH IN A DISEASED SUBJECT
#11 | 2015-11-19MCAM as a biomarker for fluid homeostasis
#12 | 2015-10-15Method to determine treatment of acute heart failure
#13 | 2015-03-26Use of aptamers in proteomics
#14 | 2014-10-09PROCATHEPSIN L AND CATHEPSIN L AS BIOMARKERS FOR ISCHEMIA
#15 | 2014-08-21TRANSACTION METHOD BASED ON THE GENETIC IDENTITY OF AN INDIVIDUAL AND TOOLS RELATED THEREOF
#16 | 2014-04-24MCAM AS A BIOMARKER FOR FLUID HOMEOSTASIS
#17 | 2013-06-13LTBP2 AS A BIOMARKER FOR EVALUATING THE RISK OF DEATH IN A DISEASED SUBJECT
#18 | 2013-05-23Perlecan as a biomarker for renal dysfunction
#19 | 2013-05-09BIOMARKER FOR HYPERTENSIVE DISORDERS OF PREGNANCY
#20 | 2013-02-21BIOMARKERS FOR HYPERTENSIVE DISORDERS OF PREGNANCY
#21 | 2013-02-14LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#22 | 2012-09-20MCAM as a biomarker for fluid homeostasis
#23 | 2012-08-30BIOMARKER FOR DIAGNOSIS, PREDICTION AND/OR PROGNOSIS OF ACUTE HEART FAILURE AND USES THEREOF
#24 | 2012-02-09Method of treating renal dysfunction based on perlecan as a biomarker
#25 | 2011-11-10BIOMARKER FOR DIAGNOSIS, PREDICTION AND/OR PROGNOSIS OF ACUTE HEART FAILURE AND USES THEREOF
#26 | 2011-10-20NOVEL POLYPEPTIDES RELATED TO B-TYPE NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE
#27 | 2011-10-13BIOMARKERS FOR HYPERTENSIVE DISORDERS OF PREGNANCY
#28 | 2011-09-29LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#29 | 2011-03-10Biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof
#30 | 2010-12-09PREPARATION OF SAMPLES FOR PROTEOME ANALYSIS
#31 | 2010-11-25USE OF APTAMERS IN PROTEOMICS
#32 | 2010-11-18BIOMARKERS AND METHODS FOR DIAGNOSING, PREDICTING AND/OR PROGNOSING SEPSIS AND USES THEREOF
#33 | 2010-09-02Protease-sensitive site in apolipoprotein A1, therapeutic and diagnostic implications
#34 | 2010-08-19USE OF N-TERMINAL AND C-TERMINAL PROTEOMICS TECHNOLOGY TO ENHANCE PROTEIN THERAPEUTICS AND DIAGNOSTICS
#35 | 2007-11-01Peptide combos and their uses
91478 ⎘